Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL; NORDIC Idiopathic Intracranial Hypertension Study Group.

Invest Ophthalmol Vis Sci. 2016 Mar;57(3):805-12. doi: 10.1167/iovs.15-18626.

2.

Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.

Cello KE, Keltner JL, Johnson CA, Wall M; NORDIC Idiopathic Intracranial Hypertension Study Group.

J Neuroophthalmol. 2016 Mar;36(1):6-12. doi: 10.1097/WNO.0000000000000327.

PMID:
26618282
3.

Positive Auto-Antibody Activity With Retina and Optic Nerve in Smokers and Non-Smokers: The Controversy Continues.

Chin EK, Almeida DR, Lam KV, Keltner JL, Thirkill CE.

Ophthalmic Surg Lasers Imaging Retina. 2015 Nov-Dec;46(10):1068-70. doi: 10.3928/23258160-20151027-17.

PMID:
26599255
4.

Fellowship training in neuro-ophthalmology in the United States.

Lee AG, Keltner JL.

J Neuroophthalmol. 2015 Mar;35(1):1-2. doi: 10.1097/WNO.0000000000000198. No abstract available.

PMID:
25546237
5.

Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension.

Rizzo JL, Lam KV, Wall M, Wilson MD, Keltner JL.

J Neuroophthalmol. 2015 Mar;35(1):22-5. doi: 10.1097/WNO.0000000000000181.

6.

Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Keltner JL, Johnson CA, Cello KE, Wall M; NORDIC Idiopathic Intracranial Hypertension Study Group.

Invest Ophthalmol Vis Sci. 2014 Apr 29;55(5):3200-7. doi: 10.1167/iovs.14-14243.

7.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ.

JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312.

8.

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group.

JAMA Neurol. 2014 Jun;71(6):693-701. doi: 10.1001/jamaneurol.2014.133.

9.

The idiopathic intracranial hypertension treatment trial: design considerations and methods.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M; NORDIC IIHTT Study Group.

J Neuroophthalmol. 2014 Jun;34(2):107-17. doi: 10.1097/WNO.0000000000000114.

PMID:
24739993
10.

Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis.

Winges KM, Werner JS, Harvey DJ, Cello KE, Durbin MK, Balcer LJ, Calabresi PA, Keltner JL.

J Neuroophthalmol. 2013 Dec;33(4):322-9. doi: 10.1097/WNO.0b013e31829c51f7.

11.

Pancreatic neuroendocrine paraneoplastic optic neuropathy: confirmation with antibody to optic nerve and hepatic metastasis.

Slamovits TL, Posner JB, Reidy DL, Thirkill CE, Keltner JL.

J Neuroophthalmol. 2013 Mar;33(1):21-5. doi: 10.1097/WNO.0b013e3182699b2a.

PMID:
22926698
12.

Undiagnosed papilledema in a morbidly obese patient population: a prospective study.

Krispel CM, Keltner JL, Smith W, Chu DG, Ali MR.

J Neuroophthalmol. 2011 Dec;31(4):310-5. doi: 10.1097/WNO.0b013e3182269910.

PMID:
21799447
13.

Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies.

Werner JS, Keltner JL, Zawadzki RJ, Choi SS.

Eye (Lond). 2011 Mar;25(3):279-89. doi: 10.1038/eye.2010.218. Epub 2011 Feb 4.

14.

Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.

Artes PH, Chauhan BC, Keltner JL, Cello KE, Johnson CA, Anderson DR, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2010 Dec;128(12):1528-32. doi: 10.1001/archophthalmol.2010.292.

15.

Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis.

Watson GM, Keltner JL, Chin EK, Harvey D, Nguyen A, Park SS.

J Neuroophthalmol. 2011 Jun;31(2):110-6. doi: 10.1097/WNO.0b013e3181facbbd.

PMID:
21131852
16.

Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging.

Choi SS, Zawadzki RJ, Lim MC, Brandt JD, Keltner JL, Doble N, Werner JS.

Br J Ophthalmol. 2011 Jan;95(1):131-41. doi: 10.1136/bjo.2010.183756. Epub 2010 Oct 17.

17.

Microstructural Abnormalities Revealed by High Resolution Imaging Systems in Central Macular Arteriovenous Malformation.

Telander DG, Choi SS, Zawadzki RJ, Berger N, Keltner JL, Werner JS.

Ophthalmic Surg Lasers Imaging. 2010 Mar 9:1-4. doi: 10.3928/15428877-20100215-99. [Epub ahead of print]

18.

Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.

Keltner JL, Johnson CA, Cello KE, Dontchev M, Gal RL, Beck RW; Optic Neuritis Study Group.

Arch Ophthalmol. 2010 Mar;128(3):330-7. doi: 10.1001/archophthalmol.2010.16.

19.

New international classification of diseases (ICD-11) needs NANOS input.

Kashii S, Keltner JL.

J Neuroophthalmol. 2009 Jun;29(2):162. doi: 10.1097/WNO.0b013e3181a6372b. No abstract available.

PMID:
19491651
20.

Fourier-domain optical coherence tomography and adaptive optics reveal nerve fiber layer loss and photoreceptor changes in a patient with optic nerve drusen.

Choi SS, Zawadzki RJ, Greiner MA, Werner JS, Keltner JL.

J Neuroophthalmol. 2008 Jun;28(2):120-5. doi: 10.1097/WNO.0b013e318175c6f5.

Supplemental Content

Loading ...
Support Center